2014, Number 4
<< Back Next >>
Revista Cubana de Cirugía 2014; 53 (4)
Giant splenomegaly in chronic lymphocytic leukemia
González GJL, Menéndez NJ
Language: Spanish
References: 11
Page: 408-414
PDF size: 360.65 Kb.
ABSTRACT
Chronic lymphocytic leukemia is the most frequent in the Western hemisphere; their
symptoms usually include adenopathy, fatigue, loss weight and those derived from
infection and anemic syndrome. Although it is one of the diseases rarely in need of
splenectomy for hyperesplenism, it is a common pathology in hematology and they
and general surgeon should have thorough knowledge about it. We introduced a
patient with a splenomegaly of giant proportions and unusual presentation.
REFERENCES
Ruiz de Gaona E, Rifón Roca JJ, Pérez-Calvo J, Bendandi M, Iglesias Santos R, Panizo C. La anemia en la leucemia linfática crónica: ¿es la eritropoyetina la solución del problema? Revista de Medicina. 2007;51(1):3-10.
Oscier D, Fegan C, Hillmen P, Illidge T, Johnson S, Maguire P, et al. Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. British Journal of Haematology. 2004;125(3):294-317.
Sgambati MT, Linet MS, Devesa SS. Chronic lymphocytic leukemia, epidemiological, familial, and genetic aspects 33-62. In: Cheson BD. Chronic Lymphoid Leukemias; Marcel Dekker Inc. USA 2001. p. 625.
Houlston RS, Catovsky D, Yuille MR. Genetic susceptibility to chronic lymphocytic leukemia. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK. 2002;16(6):1008.
Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219-34.
Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48(1):198-206.
Barcellini W, Capalbo S, Agostinelli RM, Mauro FR, Ambrosetti A, Calori R, Zanella A. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia. Haematologica, 2006;91(12):1689-92.
Leporrier M, Chevret S, Cazin B, Boudjerra N, Feugier P, Desablens B, et al. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood. 2001;98(8):2319-25.
Seymour JF, Cusack JD, Lerner SA, Pollock RE, Keating MJ. Case/control study of the role of splenectomy in chronic lymphocytic leukemia. Journal of clinical oncology. 1997;15(1):52-60.
Catovsky D, Richards S, Fooks J, Hamblin T. CLL trials in the United Kingdom. The Medical Research Council CLL Trials 1, 2, 3. Leukemia and Lymphoma. 1991;(suppl):105-7.
Chisesi T, Capnist G, Fior SD. Splenic irradiation in chronic lymphocytic leukemia. European Journal of Haematology. 1991;46(4):202-4.
Full text